Efectos gastrointestinales
rash) For less urgent concerns, contact your GP or call NHS 111
Incretin mimetics have demonstrated safety and efficacy in advanced kidney disease, however multiple studies have shown that use of GLP1-RA have shown improvements in glycemic control, body weight reductions, improved beta cell function, and decreased incidence hypoglycemia as compared to DPP4i in a general diabetes population 26,27,28,29,30,31 , effects which might explain the reduction of acute healthcare utilization observed in this study of patients with CKD treated with GLP1-RA as compared to DPP4i
In percentage terms, VAT reduction averaged 15 to 20 percent over the study period
Plan for adequate hydration throughout the day